F612-0253 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[1-(4-ethylphenyl)-5-methyl-1H-pyrazol-4-yl]quinoline-4-carboxamide

F612-0253 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[1-(4-ethylphenyl)-5-methyl-1H-pyrazol-4-yl]quinoline-4-carboxamide
F612-0253 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[1-(4-ethylphenyl)-5-methyl-1H-pyrazol-4-yl]quinoline-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F612-0253
N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[1-(4-ethylphenyl)-5-methyl-1H-pyrazol-4-yl]quinoline-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F612-0253

Molecular Formula

C30H32N4O (C30 H32 N4 O)

Compound Name

N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[1-(4-ethylphenyl)-5-methyl-1H-pyrazol-4-yl]quinoline-4-carboxamide

IUPAC name

N-[2-(cyclohex-1-en-1-yl)ethyl]-2-[1-(4-ethylphenyl)-5-methyl-1H-pyrazol-4-yl]quinoline-4-carboxamide

SMILES

CCc(cc1)ccc1-n1ncc(-c2nc3ccccc3c(C(NCCC3=CCCCC3)=O)c2)c1C

InChI

InChI=1S/C30H32N4O/c1-3-22-13-15-24(16-14-22)34-21(2)27(20-32-34)29-19-26(25-11-7-8-12-28(25)33-29)30(35)31-18-17-23-9-5-4-6-10-23/h7-9,11-16,19-20H,3-6,10,17-18H2,1-2H3,(H,31,35)

InChI Key

HQTVJRYJEVAJMQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14960678

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.61

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

6.951

Distribution Coefficient, logD

6.951

Water Solubility, LogSw

-5.65

Polar Surface Area

46.810

Acid Dissociation Constant (pKa)

15.44

Base Dissociation Constant (pKb)

0.54

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.00

F612-0253 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with F612-0253 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F612-0253?
Check Price and Availability of F612-0253, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F612-0253 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F612-0253
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F612-0253
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F612-0253 available by request